Agency classClass IIOur severity:Severe FDA (Drugs)·D-0152-2016·Announced 2015-11-04

Moses Lake Pharmacy Recalls Trimix Injectable Solution Due to Sterility Concerns

JD & SN Inc. is recalling 3 syringes of Trimix injectable solution because the FDA could not ensure the drug was sterile.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The rubric specifies that FDA Class II recalls involving significant injury or property damage, or structural defects, are Severe. While the source does not explicitly report injuries, the lack of sterility assurance in an injectable drug is a significant hazard that aligns with the Severe classification for Class II recalls where the risk is not theoretical but a confirmed lack of assurance.

Plain-English summary

JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling 3 syringes of TRIMIX, injectable Solution, 40MG/2MG/40MCG/ML. The recall was initiated because the product lacks assurance of sterility. The affected lots are identified by the codes t02272015@24, t04272015@22, and t06022015@4.

The FDA classified this recall as Class II. The distribution pattern for the recalled product is nationwide. The source text does not specify the number of units distributed or report any illnesses or injuries associated with the product.

Consumers who have this product should contact their healthcare provider or the recalling firm for instructions on how to proceed. The recall is limited to the specific syringes and lot codes listed above.

The recalled product

Product: TRIMIX, injectable Solution, 40MG/2MG/40MCG/ML, syringe size: 10mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
Manufacturer: JD & SN Inc., dba Moses Lake Professional Pharmacy
Category: Drug — Injectable Solution
Hazard: lack-of-sterility
Affected units: 3

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

t02272015@24
t04272015@22
t06022015@4.

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 101 products in this recall →

Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy

See all →

Severe
FDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
Severe
FDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Severe
Moses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Severe
Moses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Severe
FDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04

Same hazard · lack of sterility